This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Boehringer Ingelheim Animal Health do Brasil Ltda.
Boehringer Ingelheim Animal Health do Brasil Ltda., a subsidiary of the global pharmaceutical giant Boehringer Ingelheim, is headquartered in Brazil and operates extensively across the Latin American region. Founded in 1885, the company has established itself as a leader in the animal health industry, focusing on innovative solutions for livestock and companion animals. With a diverse portfolio that includes vaccines, antiparasitics, and pharmaceuticals, Boehringer Ingelheim is renowned for its commitment to research and development, ensuring high-quality products tailored to the needs of veterinarians and animal owners. The company’s unique approach to animal health, emphasising sustainability and animal welfare, has solidified its market position as a trusted partner in the veterinary community. Notable achievements include significant advancements in disease prevention and treatment, contributing to the overall health and productivity of animals in Brazil and beyond.
DitchCarbon Score
How does Boehringer Ingelheim Animal Health do Brasil Ltda.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Animal Health do Brasil Ltda.'s score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Animal Health do Brasil Ltda. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Boehringer Ingelheim GmbH, which may influence its climate commitments and performance metrics. As a part of its corporate family, Boehringer Ingelheim Animal Health do Brasil Ltda. inherits sustainability initiatives and targets from its parent company, Boehringer Ingelheim GmbH, at a cascade level of 2. However, there are no documented reduction targets or climate pledges specific to the Brazilian subsidiary. In the broader context, Boehringer Ingelheim GmbH has established various climate commitments, which may include science-based targets and sustainability initiatives aimed at reducing carbon emissions across its operations. These initiatives are crucial for aligning with global climate goals and enhancing environmental responsibility within the animal health sector. While specific emissions data and reduction targets for Boehringer Ingelheim Animal Health do Brasil Ltda. are not available, the company's affiliation with Boehringer Ingelheim GmbH suggests a commitment to sustainability and climate action in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 289,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 273,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 3,801,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Boehringer Ingelheim Animal Health do Brasil Ltda. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
